| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.32e-08 | 20 | 105 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | isomerase activity | 7.91e-07 | 192 | 105 | 9 | GO:0016853 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.21e-06 | 36 | 105 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 6.41e-06 | 50 | 105 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 8.58e-06 | 53 | 105 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | aspartate:glutamate, proton antiporter activity | 2.74e-05 | 2 | 105 | 2 | GO:0000515 | |
| GeneOntologyMolecularFunction | 3-sulfino-L-alanine: proton, glutamate antiporter activity | 2.74e-05 | 2 | 105 | 2 | GO:0000514 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.17e-05 | 37 | 105 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 4.64e-05 | 38 | 105 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | phenylalanine-tRNA ligase activity | 1.63e-04 | 4 | 105 | 2 | GO:0004826 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 2.02e-04 | 22 | 105 | 3 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 2.02e-04 | 22 | 105 | 3 | GO:0003756 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL6A6 OBSCN LAMC1 COL6A5 ERVK-7 MRPL45 ERVK-21 ERVK-9 DAP3 LMNA ERVK-5 SNTG2 ERVK-24 NUP153 | 2.35e-04 | 891 | 105 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation antiporter activity | 2.71e-04 | 5 | 105 | 2 | GO:0140848 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.95e-04 | 321 | 105 | 8 | GO:0031267 | |
| GeneOntologyMolecularFunction | 3-hydroxyacyl-CoA dehydrogenase activity | 4.05e-04 | 6 | 105 | 2 | GO:0003857 | |
| GeneOntologyMolecularFunction | GTPase binding | 6.30e-04 | 360 | 105 | 8 | GO:0051020 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 6.84e-04 | 279 | 105 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | L-aspartate transmembrane transporter activity | 1.20e-03 | 10 | 105 | 2 | GO:0015183 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-7 ERVK-21 DPP3 ADAMTS5 ERVK-9 F5 F8 MOXD1 PRICKLE3 CPO ERVK-5 ERVK-24 ZMYM6 NUP153 TPH1 | 1.37e-03 | 1189 | 105 | 15 | GO:0046914 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.42e-03 | 507 | 105 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.42e-03 | 507 | 105 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 1.46e-03 | 11 | 105 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | enoyl-CoA hydratase activity | 1.75e-03 | 12 | 105 | 2 | GO:0004300 | |
| GeneOntologyMolecularFunction | C4-dicarboxylate transmembrane transporter activity | 2.75e-03 | 15 | 105 | 2 | GO:0015556 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 2.75e-03 | 15 | 105 | 2 | GO:0005313 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.67e-10 | 9 | 104 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 5.20e-10 | 20 | 104 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 7.31e-10 | 10 | 104 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 3.69e-09 | 13 | 104 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | RGPD4 RANBP2 RGPD8 RGPD1 WDR5 SERPINA12 SLC25A12 SLC25A13 RGPD3 | 4.89e-09 | 111 | 104 | 9 | GO:0006094 |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 5.71e-09 | 14 | 104 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | RGPD4 RANBP2 RGPD8 RGPD1 WDR5 SERPINA12 SLC25A12 SLC25A13 RGPD3 | 6.69e-09 | 115 | 104 | 9 | GO:0019319 |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | RGPD4 RANBP2 RGPD8 RGPD1 WDR5 SERPINA12 SLC25A12 SLC25A13 RGPD3 | 1.05e-08 | 121 | 104 | 9 | GO:0046364 |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.56e-08 | 134 | 104 | 9 | GO:0010906 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 6.89e-08 | 71 | 104 | 7 | GO:0006111 | |
| GeneOntologyBiologicalProcess | RNA transport | 2.55e-07 | 175 | 104 | 9 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 2.55e-07 | 175 | 104 | 9 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.95e-07 | 178 | 104 | 9 | GO:0051236 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | RGPD4 RANBP2 RGPD8 RGPD1 WDR5 SERPINA12 SLC25A12 SLC25A13 RGPD3 FGL1 | 4.40e-07 | 244 | 104 | 10 | GO:0006006 |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | RGPD4 RANBP2 UXS1 RGPD8 RGPD1 WDR5 SERPINA12 SLC25A12 SLC25A13 RGPD3 FGL1 | 4.77e-07 | 310 | 104 | 11 | GO:0005996 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 6.36e-07 | 195 | 104 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | mRNA transport | 7.16e-07 | 145 | 104 | 8 | GO:0051028 | |
| GeneOntologyBiologicalProcess | import into nucleus | 8.19e-07 | 201 | 104 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.30e-06 | 38 | 104 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.55e-06 | 217 | 104 | 9 | GO:0006403 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | RGPD4 RANBP2 RGPD8 RGPD1 WDR5 SERPINA12 SLC25A12 SLC25A13 RGPD3 FGL1 | 1.75e-06 | 284 | 104 | 10 | GO:0019318 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 2.59e-06 | 231 | 104 | 9 | GO:0006109 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 RANBP2 RGPD8 RGPD1 NUP42 LMNA KHDRBS1 CD36 RGPD3 NUP153 RGPD5 | 3.29e-06 | 378 | 104 | 11 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 RANBP2 RGPD8 RGPD1 NUP42 LMNA KHDRBS1 CD36 RGPD3 NUP153 RGPD5 | 3.29e-06 | 378 | 104 | 11 | GO:0006913 |
| GeneOntologyBiologicalProcess | nuclear export | 4.45e-06 | 185 | 104 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | RGPD4 RANBP2 RGPD8 RGPD1 WDR5 SERPINA12 SLC25A12 SLC25A13 RGPD3 | 4.47e-06 | 247 | 104 | 9 | GO:0016051 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 4.75e-06 | 132 | 104 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 4.78e-06 | 249 | 104 | 9 | GO:0015931 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 7.69e-06 | 54 | 104 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | protein folding | 3.51e-05 | 246 | 104 | 8 | GO:0006457 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 SEC16B RANBP2 RGPD8 MYO1C ITSN1 RGPD1 VPS16 NUP42 OPA1 MREG UBE2O LMNA KHDRBS1 CD36 RGPD3 ERP29 BBS12 NUP153 RGPD5 | 5.07e-05 | 1496 | 104 | 20 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | RGPD4 RANBP2 RGPD8 RGPD1 WDR5 SERPINA12 SLC25A12 RGPD3 FGF1 FGL1 | 6.87e-05 | 434 | 104 | 10 | GO:0062012 |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 SEC16B RANBP2 RGPD8 RGPD1 VPS16 NUP42 LMNA CD36 RGPD3 ERP29 NUP153 RGPD5 | 8.89e-05 | 740 | 104 | 13 | GO:0006886 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 9.08e-05 | 362 | 104 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | phenylalanyl-tRNA aminoacylation | 1.50e-04 | 4 | 104 | 2 | GO:0006432 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | RGPD4 RANBP2 RGPD8 RGPD1 WDR5 SERPINA12 MOXD1 SLC25A12 SLC25A13 RGPD3 FGF1 KYNU | 1.53e-04 | 676 | 104 | 12 | GO:0044283 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | RGPD4 RANBP2 SYNPO2 SASH1 RGPD8 RGPD1 CARTPT PTPRB RGPD3 PAK2 FGF1 ERP29 | 1.76e-04 | 686 | 104 | 12 | GO:0043549 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 2.11e-04 | 405 | 104 | 9 | GO:0033674 | |
| GeneOntologyBiologicalProcess | malate-aspartate shuttle | 2.49e-04 | 5 | 104 | 2 | GO:0043490 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein complex assembly | 2.64e-04 | 25 | 104 | 3 | GO:0051131 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | RGPD4 RANBP2 UXS1 RGPD8 RGPD1 WDR5 SERPINA12 SLC25A12 SLC25A13 RGPD3 FGL1 | 4.16e-04 | 646 | 104 | 11 | GO:0005975 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | RGPD4 RANBP2 SYNPO2 SASH1 RGPD8 RGPD1 CARTPT PTPRB RGPD3 PAK2 FGF1 ERP29 | 7.81e-04 | 810 | 104 | 12 | GO:0051338 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 8.36e-04 | 490 | 104 | 9 | GO:0051347 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to insulin stimulus | 9.24e-04 | 38 | 104 | 3 | GO:1900078 | |
| GeneOntologyCellularComponent | annulate lamellae | 4.80e-11 | 14 | 108 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.85e-10 | 8 | 108 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.92e-10 | 18 | 108 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 6.04e-10 | 20 | 108 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 8.28e-10 | 10 | 108 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | nuclear pore | 5.30e-08 | 101 | 108 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 6.39e-08 | 21 | 108 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | inclusion body | 7.24e-06 | 90 | 108 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | phenylalanine-tRNA ligase complex | 2.64e-05 | 2 | 108 | 2 | GO:0009328 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 5.68e-05 | 332 | 108 | 9 | GO:0005788 | |
| GeneOntologyCellularComponent | nuclear envelope | CYBB RGPD4 RANBP2 RGPD8 ITSN1 RGPD1 NUP42 LMNA RGPD3 NUP153 RGPD5 | 1.53e-04 | 560 | 108 | 11 | GO:0005635 |
| GeneOntologyCellularComponent | organelle envelope | CYBB RGPD4 RANBP2 RGPD8 ITSN1 RGPD1 MRPL45 NUP42 OPA1 DAP3 SLC25A12 NDUFAF1 LMNA SLC25A13 RGPD3 HADHB NUP153 RGPD5 | 3.85e-04 | 1435 | 108 | 18 | GO:0031967 |
| GeneOntologyCellularComponent | nuclear membrane | 4.60e-04 | 349 | 108 | 8 | GO:0031965 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.38e-03 | 93 | 108 | 4 | GO:0031091 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 RANBP2 RGPD8 MYO1C ORC3 RGPD1 WDR5 COPS3 HEATR1 NUP42 MBD3 RGPD3 CPSF1 NUP153 RGPD5 BRMS1 | 1.86e-03 | 1377 | 108 | 16 | GO:0140513 |
| HumanPheno | Hepatic steatosis | 1.72e-06 | 180 | 34 | 9 | HP:0001397 | |
| HumanPheno | Lipid accumulation in hepatocytes | 2.07e-06 | 184 | 34 | 9 | HP:0006561 | |
| HumanPheno | Storage in hepatocytes | 2.95e-06 | 192 | 34 | 9 | HP:0031137 | |
| HumanPheno | Abnormal liver metabolite concentration | 4.68e-06 | 203 | 34 | 9 | HP:0034644 | |
| HumanPheno | Abnormal tissue metabolite concentration | OBSCN FARSB BBS10 FARSA NDUFAF1 LMNA SLC25A13 HADHB HSD17B4 BBS12 | 7.38e-06 | 275 | 34 | 10 | HP:0032243 |
| MousePheno | elevated level of mitotic sister chromatid exchange | 2.25e-08 | 16 | 80 | 5 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 3.24e-07 | 26 | 80 | 5 | MP:0012058 | |
| MousePheno | decreased tumor latency | 6.89e-07 | 30 | 80 | 5 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 8.18e-07 | 31 | 80 | 5 | MP:0012129 | |
| MousePheno | aneuploidy | 1.26e-06 | 61 | 80 | 6 | MP:0004024 | |
| MousePheno | abnormal tumor latency | 1.32e-06 | 34 | 80 | 5 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 2.67e-06 | 39 | 80 | 5 | MP:0012128 | |
| MousePheno | abnormal rod electrophysiology | 5.16e-06 | 119 | 80 | 7 | MP:0004021 | |
| MousePheno | abnormal chromosome number | 9.49e-06 | 86 | 80 | 6 | MP:0004023 | |
| MousePheno | abnormal eye electrophysiology | 4.68e-05 | 228 | 80 | 8 | MP:0005551 | |
| MousePheno | increased hepatocellular carcinoma incidence | 4.89e-05 | 70 | 80 | 5 | MP:0003331 | |
| MousePheno | increased lung carcinoma incidence | 8.24e-05 | 78 | 80 | 5 | MP:0008714 | |
| MousePheno | abnormal chromosome morphology | 8.29e-05 | 126 | 80 | 6 | MP:0003702 | |
| MousePheno | abnormal mitosis | 9.05e-05 | 128 | 80 | 6 | MP:0004046 | |
| MousePheno | enlarged epididymis | 2.54e-04 | 99 | 80 | 5 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 2.92e-04 | 102 | 80 | 5 | MP:0002032 | |
| MousePheno | increased liver triglyceride level | 3.34e-04 | 105 | 80 | 5 | MP:0009355 | |
| MousePheno | increased respiratory system tumor incidence | 3.65e-04 | 107 | 80 | 5 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 3.65e-04 | 107 | 80 | 5 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 3.65e-04 | 107 | 80 | 5 | MP:0003694 | |
| MousePheno | abnormal susceptibility to weight gain | 3.79e-04 | 309 | 80 | 8 | MP:0011117 | |
| MousePheno | impaired glucose tolerance | 3.96e-04 | 480 | 80 | 10 | MP:0005293 | |
| MousePheno | increased hepatobiliary system tumor incidence | 4.32e-04 | 111 | 80 | 5 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 4.32e-04 | 111 | 80 | 5 | MP:0008019 | |
| MousePheno | abnormal blastocyst hatching | 4.69e-04 | 113 | 80 | 5 | MP:0003693 | |
| MousePheno | abnormal PR interval | 5.17e-04 | 65 | 80 | 4 | MP:0003901 | |
| MousePheno | abnormal cell nucleus morphology | 6.43e-04 | 184 | 80 | 6 | MP:0003111 | |
| MousePheno | decreased susceptibility to weight gain | 6.80e-04 | 186 | 80 | 6 | MP:0010182 | |
| Domain | Ran_BP1 | 2.18e-11 | 12 | 103 | 6 | PF00638 | |
| Domain | RANBD1 | 2.18e-11 | 12 | 103 | 6 | PS50196 | |
| Domain | RanBD | 4.04e-11 | 13 | 103 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 4.04e-11 | 13 | 103 | 6 | IPR000156 | |
| Domain | Grip | 2.08e-09 | 11 | 103 | 5 | SM00755 | |
| Domain | GRIP | 2.08e-09 | 11 | 103 | 5 | PF01465 | |
| Domain | GRIP_dom | 3.55e-09 | 12 | 103 | 5 | IPR000237 | |
| Domain | GRIP | 3.55e-09 | 12 | 103 | 5 | PS50913 | |
| Domain | GCC2_Rab_bind | 3.01e-08 | 7 | 103 | 4 | IPR032023 | |
| Domain | Rab_bind | 3.01e-08 | 7 | 103 | 4 | PF16704 | |
| Domain | - | 1.79e-07 | 10 | 103 | 4 | 1.10.220.60 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RGPD8 ITSN1 OBSCN RGPD1 PTPN13 RGPD3 SNTG2 RGPD5 SOS1 | 2.32e-05 | 426 | 103 | 11 | IPR011993 |
| Domain | Factor_5/8 | 3.01e-05 | 2 | 103 | 2 | IPR024715 | |
| Domain | Qua1 | 9.00e-05 | 3 | 103 | 2 | PF16274 | |
| Domain | Qua1_dom | 9.00e-05 | 3 | 103 | 2 | IPR032571 | |
| Domain | Sam68-YY | 9.00e-05 | 3 | 103 | 2 | IPR032335 | |
| Domain | Sam68-YY | 9.00e-05 | 3 | 103 | 2 | PF16568 | |
| Domain | TPR-contain_dom | 1.83e-04 | 150 | 103 | 6 | IPR013026 | |
| Domain | Cu_oxidase_CS | 2.98e-04 | 5 | 103 | 2 | IPR033138 | |
| Domain | Cu-oxidase_3 | 2.98e-04 | 5 | 103 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 2.98e-04 | 5 | 103 | 2 | PS00079 | |
| Domain | Cu-oxidase_3 | 2.98e-04 | 5 | 103 | 2 | PF07732 | |
| Domain | TPR_REGION | 3.06e-04 | 165 | 103 | 6 | PS50293 | |
| Domain | TPR | 3.06e-04 | 165 | 103 | 6 | PS50005 | |
| Domain | TPR-like_helical_dom | 3.08e-04 | 233 | 103 | 7 | IPR011990 | |
| Domain | - | 3.13e-04 | 391 | 103 | 9 | 2.30.29.30 | |
| Domain | Cu_oxidase_Cu_BS | 4.45e-04 | 6 | 103 | 2 | IPR002355 | |
| Domain | TLV_coat | 6.21e-04 | 7 | 103 | 2 | PF00429 | |
| Domain | TPR | 7.41e-04 | 129 | 103 | 5 | SM00028 | |
| Domain | TLV/ENV_coat_polyprotein | 8.25e-04 | 8 | 103 | 2 | IPR018154 | |
| Domain | TPR_repeat | 8.51e-04 | 133 | 103 | 5 | IPR019734 | |
| Domain | PDZ | 1.11e-03 | 141 | 103 | 5 | PF00595 | |
| Domain | KH_1 | 1.19e-03 | 38 | 103 | 3 | PF00013 | |
| Domain | GDS_CDC24_CS | 1.29e-03 | 39 | 103 | 3 | IPR001331 | |
| Domain | - | 1.29e-03 | 39 | 103 | 3 | 3.30.1370.10 | |
| Domain | PDZ | 1.37e-03 | 148 | 103 | 5 | SM00228 | |
| Domain | KH | 1.39e-03 | 40 | 103 | 3 | SM00322 | |
| Domain | KH_dom | 1.39e-03 | 40 | 103 | 3 | IPR004087 | |
| Domain | - | 1.45e-03 | 150 | 103 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.50e-03 | 151 | 103 | 5 | PS50106 | |
| Domain | PDZ | 1.54e-03 | 152 | 103 | 5 | IPR001478 | |
| Domain | TPR_1 | 1.55e-03 | 90 | 103 | 4 | PF00515 | |
| Domain | TPR_1 | 1.55e-03 | 90 | 103 | 4 | IPR001440 | |
| Domain | KH_TYPE_1 | 1.60e-03 | 42 | 103 | 3 | PS50084 | |
| Domain | Galactose-bd-like | 1.82e-03 | 94 | 103 | 4 | IPR008979 | |
| Domain | KH_dom_type_1 | 1.83e-03 | 44 | 103 | 3 | IPR004088 | |
| Domain | - | 2.62e-03 | 14 | 103 | 2 | 2.60.40.420 | |
| Domain | - | 2.62e-03 | 14 | 103 | 2 | 1.10.560.10 | |
| Domain | GROEL-like_equatorial | 2.62e-03 | 14 | 103 | 2 | IPR027413 | |
| Domain | Cpn60/TCP-1 | 3.02e-03 | 15 | 103 | 2 | IPR002423 | |
| Domain | Cpn60_TCP1 | 3.02e-03 | 15 | 103 | 2 | PF00118 | |
| Domain | - | 3.02e-03 | 15 | 103 | 2 | 3.50.7.10 | |
| Domain | GroEL-like_apical_dom | 3.02e-03 | 15 | 103 | 2 | IPR027409 | |
| Domain | VWA | 3.65e-03 | 56 | 103 | 3 | PF00092 | |
| Domain | DH_1 | 5.09e-03 | 63 | 103 | 3 | PS00741 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.71e-10 | 50 | 78 | 8 | MM14610 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 6.01e-10 | 55 | 78 | 8 | MM14917 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.94e-09 | 40 | 78 | 7 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.33e-09 | 41 | 78 | 7 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.79e-09 | 42 | 78 | 7 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.31e-09 | 43 | 78 | 7 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 6.35e-09 | 47 | 78 | 7 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 8.60e-09 | 49 | 78 | 7 | MM14837 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.15e-08 | 51 | 78 | 7 | MM15151 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.28e-08 | 86 | 78 | 8 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.89e-08 | 58 | 78 | 7 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.89e-08 | 58 | 78 | 7 | MM14736 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.69e-08 | 18 | 78 | 5 | MM1549 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.49e-08 | 65 | 78 | 7 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.47e-07 | 73 | 78 | 7 | MM14948 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.09e-07 | 114 | 78 | 8 | MM15361 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.29e-07 | 82 | 78 | 7 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 3.89e-07 | 84 | 78 | 7 | MM14929 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 7.25e-07 | 92 | 78 | 7 | MM14951 | |
| Pathway | REACTOME_SUMOYLATION | 4.06e-05 | 169 | 78 | 7 | MM14919 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 7.83e-05 | 129 | 78 | 6 | MM14894 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 9.09e-05 | 43 | 78 | 4 | M26975 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.43e-04 | 277 | 78 | 8 | MM15414 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.07e-04 | 53 | 78 | 4 | M27212 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.28e-04 | 100 | 78 | 5 | MM14561 | |
| Pathway | REACTOME_M_PHASE | 2.76e-04 | 387 | 78 | 9 | MM15364 | |
| Pathway | REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING | 2.99e-04 | 5 | 78 | 2 | M27731 | |
| Pathway | REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING | 2.99e-04 | 5 | 78 | 2 | MM15481 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 3.08e-04 | 234 | 78 | 7 | MM14898 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 3.13e-04 | 59 | 78 | 4 | M27606 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.71e-04 | 117 | 78 | 5 | MM15387 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 4.83e-04 | 28 | 78 | 3 | MM1396 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 5.41e-04 | 257 | 78 | 7 | MM14755 | |
| Pathway | BIOCARTA_FAS_PATHWAY | 5.94e-04 | 30 | 78 | 3 | M9503 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 6.91e-04 | 193 | 78 | 6 | MM14890 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 7.20e-04 | 32 | 78 | 3 | M29579 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 7.41e-04 | 271 | 78 | 7 | MM15406 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 7.89e-04 | 33 | 78 | 3 | M27016 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 8.28e-04 | 8 | 78 | 2 | M26926 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CYBB RGPD4 RANBP2 RGPD8 ITSN1 OBSCN RGPD1 PTPN13 RGPD3 PAK2 SOS1 | 8.47e-04 | 649 | 78 | 11 | MM15690 |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 8.62e-04 | 34 | 78 | 3 | M27041 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 8.76e-04 | 202 | 78 | 6 | MM15362 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 9.39e-04 | 35 | 78 | 3 | M27320 | |
| Pathway | WP_FAS_PATHWAY_AND_STRESS_INDUCTION_OF_HSP_REGULATION | 1.02e-03 | 36 | 78 | 3 | MM15967 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.02e-03 | 36 | 78 | 3 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.02e-03 | 36 | 78 | 3 | M27245 | |
| Pathway | REACTOME_MALATE_ASPARTATE_SHUTTLE | 1.06e-03 | 9 | 78 | 2 | M48269 | |
| Pathway | REACTOME_MALATE_ASPARTATE_SHUTTLE | 1.06e-03 | 9 | 78 | 2 | MM17242 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 1.06e-03 | 9 | 78 | 2 | MM14524 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.10e-03 | 141 | 78 | 5 | MM15266 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.11e-03 | 37 | 78 | 3 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 1.11e-03 | 37 | 78 | 3 | M27038 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.20e-03 | 38 | 78 | 3 | MM14969 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.20e-03 | 84 | 78 | 4 | M725 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.29e-03 | 39 | 78 | 3 | M27238 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.49e-03 | 41 | 78 | 3 | M29574 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 1.61e-03 | 11 | 78 | 2 | M22033 | |
| Pathway | REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM | 1.61e-03 | 11 | 78 | 2 | M27836 | |
| Pathway | REACTOME_CELL_CYCLE | 1.74e-03 | 603 | 78 | 10 | MM14635 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.83e-03 | 44 | 78 | 3 | M109 | |
| Pathway | REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM | 1.92e-03 | 12 | 78 | 2 | MM15556 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.08e-03 | 46 | 78 | 3 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.22e-03 | 47 | 78 | 3 | M27395 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 2.27e-03 | 13 | 78 | 2 | M6322 | |
| Pubmed | 3.98e-13 | 11 | 110 | 6 | 17069463 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.47e-12 | 13 | 110 | 6 | 31427429 | |
| Pubmed | 4.26e-12 | 15 | 110 | 6 | 14697343 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 6.03e-12 | 7 | 110 | 5 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 6.03e-12 | 7 | 110 | 5 | 11353387 | |
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 30944974 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 6.03e-12 | 7 | 110 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 6.03e-12 | 7 | 110 | 5 | 17372272 | |
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 38657106 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 21205196 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 18949001 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 25187515 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 8603673 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 26632511 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 24403063 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 23818861 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 23536549 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 12191015 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 22821000 | ||
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.60e-11 | 8 | 110 | 5 | 21670213 | |
| Pubmed | 1.60e-11 | 8 | 110 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.60e-11 | 8 | 110 | 5 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.60e-11 | 8 | 110 | 5 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.60e-11 | 8 | 110 | 5 | 28745977 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.04e-11 | 38 | 110 | 7 | 12791264 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 3.60e-11 | 9 | 110 | 5 | 18394993 | |
| Pubmed | 3.60e-11 | 9 | 110 | 5 | 28100513 | ||
| Pubmed | 3.60e-11 | 9 | 110 | 5 | 17887960 | ||
| Pubmed | 3.60e-11 | 9 | 110 | 5 | 11553612 | ||
| Pubmed | 3.60e-11 | 9 | 110 | 5 | 10601307 | ||
| Pubmed | 3.60e-11 | 9 | 110 | 5 | 9733766 | ||
| Pubmed | 3.60e-11 | 9 | 110 | 5 | 28877029 | ||
| Pubmed | 7.18e-11 | 10 | 110 | 5 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 7.18e-11 | 10 | 110 | 5 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 7.18e-11 | 10 | 110 | 5 | 8857542 | |
| Pubmed | 7.18e-11 | 10 | 110 | 5 | 21859863 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 WAPL MYO1C FARSB WDR5 COPS3 POGZ HEATR1 MBD3 OPA1 DAP3 FARSA UBE2O NAMPT TXNDC5 LMNA KHDRBS1 SLC25A13 CPSF1 ERP29 HADHB HSD17B4 NUP153 | 9.80e-11 | 1425 | 110 | 23 | 30948266 |
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.31e-10 | 11 | 110 | 5 | 35771867 | |
| Pubmed | 1.31e-10 | 11 | 110 | 5 | 34110283 | ||
| Pubmed | 1.04e-09 | 99 | 110 | 8 | 27746211 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | RGPD4 RANBP2 RGPD8 RGPD1 FARSB TXNDC5 LMNA KHDRBS1 RGPD3 HADHB | 2.93e-09 | 226 | 110 | 10 | 37839992 |
| Pubmed | 7.28e-09 | 22 | 110 | 5 | 27717094 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.13e-08 | 94 | 110 | 7 | 21542922 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.27e-08 | 146 | 110 | 8 | 23892456 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 3.27e-08 | 153 | 110 | 8 | 26365490 | |
| Pubmed | RANBP2 ORC3 FARSB WDR5 COPS3 MRPL45 NUP42 MBD3 OPA1 DAP3 FARSA UBE2O SLC25A12 TXNDC5 LMNA KHDRBS1 SLC25A13 HADHB HSD17B4 | 3.87e-08 | 1335 | 110 | 19 | 29229926 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.59e-08 | 231 | 110 | 9 | 16452087 | |
| Pubmed | EEFSEC RANBP2 MYO1C WDR5 HEATR1 ITIH2 QSOX1 FARSA UBE2O TXNDC5 KHDRBS1 SLC25A13 HADHB HSD17B4 | 5.92e-08 | 711 | 110 | 14 | 33022573 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | RANBP2 ESD FARSB DAP3 FARSA NAMPT LMNA KHDRBS1 SLC25A13 CPSF1 ERP29 HADHB HSD17B4 | 6.93e-08 | 607 | 110 | 13 | 39147351 |
| Pubmed | RGPD4 RANBP2 RGPD8 MYO1C RGPD1 FARSB HEATR1 OPA1 QSOX1 FARSA LMNA SLC25A13 RGPD3 HADHB RGPD5 | 7.29e-08 | 844 | 110 | 15 | 25963833 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 RANBP2 RGPD8 MYO1C ITSN1 WDR5 OPA1 LMNA KHDRBS1 SLC25A13 RGPD3 HADHB RGPD5 | 9.89e-08 | 626 | 110 | 13 | 33644029 |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 9480752 | ||
| Pubmed | RANBP2 ITSN1 ZDHHC5 NUP42 UBE2O PTPN13 KHDRBS1 NUP153 AHNAK2 | 1.68e-07 | 263 | 110 | 9 | 34702444 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RANBP2 WAPL ORC3 FARSB WDR5 HEATR1 OPA1 DAP3 FARSA NAMPT SLC25A12 LMNA SLC25A13 PAK2 DDX43 HADHB HSD17B4 NUP153 | 1.70e-07 | 1318 | 110 | 18 | 30463901 |
| Pubmed | MAGI1 ITSN1 HEATR1 NUP42 MBD3 FARSA SLC25A12 TXNDC5 LMNA CPSF1 PAK2 HADHB HSD17B4 NUP153 SOS1 | 2.09e-07 | 916 | 110 | 15 | 32203420 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 WAPL MYO1C FARSB WDR5 COPS3 POGZ HEATR1 VPS16 NAMPT SLC25A12 LMNA SLC25A13 CPSF1 ERP29 DDX43 HADHB AHNAK2 | 2.50e-07 | 1353 | 110 | 18 | 29467282 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANBP2 KHDRBS2 MRPL45 POGZ MBD3 OPA1 DAP3 FARSA PTPN13 SLC25A12 LMNA KHDRBS1 SLC25A13 CPSF1 HADHB HSD17B4 | 3.11e-07 | 1082 | 110 | 16 | 38697112 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 RANBP2 RGPD8 MYO1C RGPD1 FARSB OPA1 FARSA NAMPT SLC25A12 KHDRBS1 SLC25A13 RGPD3 CPSF1 HADHB HSD17B4 RGPD5 | 4.46e-07 | 1257 | 110 | 17 | 37317656 |
| Pubmed | RGPD4 RANBP2 RGPD8 MYO1C ITSN1 KHDRBS2 RGPD1 HEATR1 DAP3 SLC25A12 LMNA KHDRBS1 SLC25A13 RGPD3 DLEC1 HADHB HSD17B4 RGPD5 | 6.29e-07 | 1442 | 110 | 18 | 35575683 | |
| Pubmed | RANBP2 WAPL ORC3 ESD FARSB WDR5 MBD3 FARSA NAMPT KHDRBS1 CPSF1 PAK2 MYO15A KYNU NUP153 | 7.51e-07 | 1014 | 110 | 15 | 32416067 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 RANBP2 RGPD8 MYO1C RGPD1 FARSB FARSA NAMPT SLC25A12 LMNA RGPD3 HADHB | 1.38e-06 | 665 | 110 | 12 | 30457570 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYO1C ESD COPS3 DPP3 NAMPT TXNDC5 LMNA KHDRBS1 ERP29 HADHB MYO15A KYNU AHNAK2 | 1.72e-06 | 807 | 110 | 13 | 30575818 |
| Pubmed | EEFSEC RANBP2 ORC3 FARSB COPS3 POGZ DPP3 MBD3 TXNDC5 KHDRBS1 PAK2 ERP29 HADHB HSD17B4 NUP153 | 2.12e-06 | 1103 | 110 | 15 | 34189442 | |
| Pubmed | RGPD4 MAGI1 RANBP2 RGPD8 ITSN1 RGPD1 FARSB MBD3 OPA1 FARSA UBE2O RGPD3 PAK2 NUP153 | 2.22e-06 | 963 | 110 | 14 | 28671696 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANBP2 FARSB HEATR1 VPS16 DAP3 FARSA NAMPT SLC25A12 KHDRBS1 SLC25A13 RGPD3 HADHB | 2.49e-06 | 704 | 110 | 12 | 29955894 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.74e-06 | 123 | 110 | 6 | 26912792 | |
| Pubmed | MAGI1 RANBP2 SYNPO2 ITSN1 POGZ NUP42 KHDRBS1 PAK2 NUP153 SOS1 | 3.49e-06 | 486 | 110 | 10 | 20936779 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | MYO1C F5 SLC39A8 MOXD1 PTPN13 LMNA KHDRBS1 SLC25A13 HADHB HSD17B4 SLC16A10 | 3.57e-06 | 604 | 110 | 11 | 37616343 |
| Pubmed | OBSCN LAMC1 OPA1 DAP3 SLC25A12 NDUFAF1 SLC25A13 HADHB HSD17B4 | 3.71e-06 | 382 | 110 | 9 | 29222160 | |
| Pubmed | MYO1C COPS3 FARSA UBE2O TXNDC5 LMNA KHDRBS1 SLC25A13 HADHB BRMS1 | 3.82e-06 | 491 | 110 | 10 | 36273042 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 4.06e-06 | 289 | 110 | 8 | 23752268 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | WAPL COL6A6 OBSCN COPS3 OPA1 SNX14 PTPRB SLC25A12 SLC25A13 CPSF1 | 4.25e-06 | 497 | 110 | 10 | 36774506 |
| Pubmed | RANBP2 HEATR1 UBE2O NAMPT TXNDC5 LMNA KHDRBS1 SLC25A13 HADHB HSD17B4 NUP153 | 6.00e-06 | 638 | 110 | 11 | 33239621 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SEC16B RANBP2 WAPL MYO1C ITSN1 POGZ QSOX1 LMNA PRICKLE3 CPSF1 NUP153 SOS1 | 6.51e-06 | 774 | 110 | 12 | 15302935 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 RANBP2 MYO1C RGPD1 ITIH2 DAP3 SLC25A12 LMNA SLC25A13 HSD17B4 EXOC7 | 6.85e-06 | 647 | 110 | 11 | 26618866 |
| Pubmed | RANBP2 WDR5 MBD3 OPA1 FARSA TXNDC5 LMNA SLC25A13 HSD17B4 NUP153 BRMS1 | 7.68e-06 | 655 | 110 | 11 | 35819319 | |
| Pubmed | 8.20e-06 | 86 | 110 | 5 | 37253089 | ||
| Pubmed | RANBP2 MYO1C ORC3 ZDHHC5 WDR5 HEATR1 F5 TXNDC5 LMNA CPSF1 HADHB | 8.25e-06 | 660 | 110 | 11 | 32780723 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26599105 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25410934 | ||
| Pubmed | Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. | 9.91e-06 | 2 | 110 | 2 | 20850423 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 29573043 | ||
| Pubmed | The molecular basis of factor V and VIII procofactor activation. | 9.91e-06 | 2 | 110 | 2 | 19765210 | |
| Pubmed | ITSN1 regulates SAM68 solubility through SH3 domain interactions with SAM68 proline-rich motifs. | 9.91e-06 | 2 | 110 | 2 | 32780150 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28057741 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20223217 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20827784 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 15735794 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18826608 | ||
| Pubmed | Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism. | 9.91e-06 | 2 | 110 | 2 | 17287628 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19190184 | ||
| Pubmed | Activated protein C has a regulatory role in factor VIII function. | 9.91e-06 | 2 | 110 | 2 | 33512448 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 11858721 | ||
| Pubmed | Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers. | 9.91e-06 | 2 | 110 | 2 | 11091190 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 17213189 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18984154 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23555306 | ||
| Interaction | RGPD4 interactions | 9.53e-10 | 22 | 101 | 6 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 3.71e-09 | 27 | 101 | 6 | int:RGPD2 | |
| Interaction | NPIPB6 interactions | 2.33e-08 | 18 | 101 | 5 | int:NPIPB6 | |
| Interaction | RGPD8 interactions | 8.80e-08 | 74 | 101 | 7 | int:RGPD8 | |
| Interaction | RGPD3 interactions | 1.24e-07 | 47 | 101 | 6 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 1.60e-07 | 49 | 101 | 6 | int:RGPD1 | |
| Interaction | BIRC3 interactions | RANBP2 WAPL MYO1C FARSB WDR5 COPS3 POGZ HEATR1 MBD3 DAP3 FARSA NAMPT TXNDC5 LMNA KHDRBS1 SLC25A13 CPSF1 ERP29 HADHB HSD17B4 NUP153 | 2.30e-06 | 1334 | 101 | 21 | int:BIRC3 |
| Interaction | RAN interactions | RGPD4 RANBP2 RGPD8 RGPD1 WDR5 NUP42 MBD3 UBE2O LMNA RGPD3 NUP153 RGPD5 | 4.57e-06 | 475 | 101 | 12 | int:RAN |
| Interaction | RCC1 interactions | 7.79e-06 | 201 | 101 | 8 | int:RCC1 | |
| Interaction | RGPD5 interactions | 8.78e-06 | 96 | 101 | 6 | int:RGPD5 | |
| Interaction | NXF1 interactions | EEFSEC MAGI1 RANBP2 FAT4 OBSCN RGPD1 FARSB WDR5 POGZ NUP42 DAP3 SNX14 UBE2O NAMPT LMNA CPSF1 EXOC7 KYNU NUP153 RGPD5 | 9.78e-06 | 1345 | 101 | 20 | int:NXF1 |
| Interaction | RANBP2 interactions | RGPD4 RANBP2 RGPD8 RHBDF2 RGPD1 WDR5 LMNA RGPD3 NUP153 RGPD5 | 1.36e-05 | 361 | 101 | 10 | int:RANBP2 |
| Interaction | NUP107 interactions | 1.55e-05 | 221 | 101 | 8 | int:NUP107 | |
| Interaction | AGR2 interactions | MAGI1 MYO1C ESD COPS3 POGZ DPP3 MBD3 NAMPT TXNDC5 LMNA KHDRBS1 ERP29 HADHB MYO15A KYNU AHNAK2 | 1.57e-05 | 934 | 101 | 16 | int:AGR2 |
| Interaction | MCM2 interactions | RGPD4 RANBP2 RGPD8 ITSN1 RGPD1 FARSB HEATR1 OPA1 QSOX1 FARSA UBE2O LMNA SLC25A13 RGPD3 CPSF1 HADHB RGPD5 | 2.49e-05 | 1081 | 101 | 17 | int:MCM2 |
| Interaction | RNF43 interactions | RANBP2 ITSN1 OBSCN ZDHHC5 NUP42 UBE2O PTPN13 KHDRBS1 NUP153 AHNAK2 | 5.66e-05 | 427 | 101 | 10 | int:RNF43 |
| Interaction | RECQL4 interactions | RANBP2 ORC3 FARSB WDR5 COPS3 MRPL45 NUP42 MBD3 OPA1 DAP3 FARSA UBE2O SLC25A12 TXNDC5 LMNA KHDRBS1 SLC25A13 HADHB HSD17B4 | 6.65e-05 | 1412 | 101 | 19 | int:RECQL4 |
| Interaction | NUP43 interactions | RANBP2 RGPD8 ATP13A5 WDR5 CCDC168 POGZ HEATR1 NUP42 LMNA NUP153 AHNAK2 RGPD5 | 6.85e-05 | 625 | 101 | 12 | int:NUP43 |
| Interaction | MIDN interactions | MYO1C F5 SLC39A8 MOXD1 UBE2O PTPN13 LMNA KHDRBS1 SLC25A13 HADHB HSD17B4 SLC16A10 | 6.96e-05 | 626 | 101 | 12 | int:MIDN |
| Interaction | NUP62 interactions | 6.97e-05 | 273 | 101 | 8 | int:NUP62 | |
| Interaction | WDR5 interactions | EEFSEC RANBP2 MYO1C WDR5 HEATR1 MBD3 ITIH2 QSOX1 FARSA MOXD1 UBE2O TXNDC5 KHDRBS1 SLC25A13 HADHB HSD17B4 | 1.13e-04 | 1101 | 101 | 16 | int:WDR5 |
| Interaction | GRAP interactions | 1.31e-04 | 20 | 101 | 3 | int:GRAP | |
| Interaction | DDX43 interactions | 1.31e-04 | 20 | 101 | 3 | int:DDX43 | |
| Interaction | CT55 interactions | 1.34e-04 | 52 | 101 | 4 | int:CT55 | |
| Interaction | NUP85 interactions | 1.35e-04 | 156 | 101 | 6 | int:NUP85 | |
| Interaction | TNPO1 interactions | 1.53e-04 | 306 | 101 | 8 | int:TNPO1 | |
| Interaction | BTF3 interactions | RGPD4 RANBP2 RGPD8 MYO1C ITSN1 WDR5 OPA1 LMNA KHDRBS1 SLC25A13 RGPD3 HADHB RGPD5 | 1.77e-04 | 799 | 101 | 13 | int:BTF3 |
| Interaction | AKTIP interactions | 1.78e-04 | 104 | 101 | 5 | int:AKTIP | |
| Interaction | NR2C2 interactions | RANBP2 WAPL ORC3 FARSB WDR5 HEATR1 OPA1 DAP3 FARSA NAMPT SLC25A12 LMNA SLC25A13 PAK2 DDX43 HADHB HSD17B4 NUP153 | 1.94e-04 | 1403 | 101 | 18 | int:NR2C2 |
| Cytoband | 1q22 | 3.56e-04 | 57 | 110 | 3 | 1q22 | |
| Cytoband | 2q13 | 5.99e-04 | 68 | 110 | 3 | 2q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 7.22e-04 | 167 | 110 | 4 | chr1q25 | |
| Cytoband | 2q12.3 | 7.56e-04 | 17 | 110 | 2 | 2q12.3 | |
| Cytoband | 17q25.1 | 9.97e-04 | 81 | 110 | 3 | 17q25.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 1.03e-03 | 82 | 110 | 3 | chr2q12 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.02e-06 | 115 | 69 | 6 | 769 | |
| GeneFamily | Signal transduction and activation of RNA metabolism family | 4.30e-05 | 3 | 69 | 2 | 1275 | |
| GeneFamily | PDZ domain containing | 2.87e-04 | 152 | 69 | 5 | 1220 | |
| GeneFamily | Chaperonins | 1.46e-03 | 15 | 69 | 2 | 587 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.05e-03 | 66 | 69 | 3 | 722 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 2.35e-03 | 19 | 69 | 2 | 132 | |
| GeneFamily | Protein disulfide isomerases | 2.88e-03 | 21 | 69 | 2 | 692 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 2.88e-03 | 21 | 69 | 2 | 980 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 2.88e-03 | 21 | 69 | 2 | 89 | |
| GeneFamily | Nucleoporins | 6.61e-03 | 32 | 69 | 2 | 1051 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.85e-07 | 33 | 103 | 5 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 7.26e-07 | 43 | 103 | 5 | MM3857 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RGPD4 OGFRL1 RANBP2 CDS1 RGPD8 RHBDF2 RGPD1 NAMPT LMNA KHDRBS1 RGPD3 | 1.18e-06 | 435 | 103 | 11 | MM1221 |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP | 1.28e-06 | 200 | 103 | 8 | M6398 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D | RGPD4 RANBP2 RGPD8 MYO1C ITSN1 RGPD1 LAMC1 DPP3 CARTPT LMNA CD36 RGPD3 ERP29 BBS12 | 9.94e-06 | 888 | 103 | 14 | MM1315 |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_UP | 3.53e-05 | 410 | 103 | 9 | M4399 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-07 | 190 | 105 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-07 | 190 | 105 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.72e-06 | 175 | 105 | 6 | c9dc6aa652ac887470806a950311657c423d9495 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.17e-06 | 101 | 105 | 5 | 86acaa2502f61baa714ae988b73e3e73a71e897e | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 4.51e-06 | 181 | 105 | 6 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.66e-06 | 182 | 105 | 6 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 5.12e-06 | 185 | 105 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 5.12e-06 | 185 | 105 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 5.78e-06 | 189 | 105 | 6 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.96e-06 | 190 | 105 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.52e-06 | 193 | 105 | 6 | 5703a6faaee82cbad5ce73429bdf1b0f47b37ee0 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.72e-06 | 194 | 105 | 6 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.72e-06 | 194 | 105 | 6 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.12e-06 | 196 | 105 | 6 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | NS-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.33e-06 | 197 | 105 | 6 | 5fb0696376a5501b7c87e0f2f5e4fff3da2903f2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.55e-06 | 198 | 105 | 6 | dc59442e6a5127d3071a036c206732a21e456a17 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 198 | 105 | 6 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 198 | 105 | 6 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.77e-06 | 199 | 105 | 6 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.77e-06 | 199 | 105 | 6 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.77e-06 | 199 | 105 | 6 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 2.42e-05 | 145 | 105 | 5 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | droplet-Fat-Scat-21m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 165 | 105 | 5 | 3f0c2486ea357d10dad0b703cf75cc29bdd5b5cf | |
| ToppCell | Club-club-12|World / Class top | 4.48e-05 | 165 | 105 | 5 | 9b7a31cbdcd2f96b8bd08a4cd4141b92bd5e9062 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.77e-05 | 174 | 105 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 175 | 105 | 5 | cd42020fe57afeaadfbd3ef6d7375e66d71e9669 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 175 | 105 | 5 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 175 | 105 | 5 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 175 | 105 | 5 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 6.09e-05 | 176 | 105 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | droplet-Marrow-nan-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 176 | 105 | 5 | f92063b72ebfeb9b192281dc63d6bf2759c78554 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 6.09e-05 | 176 | 105 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 178 | 105 | 5 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.60e-05 | 179 | 105 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.77e-05 | 180 | 105 | 5 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.14e-05 | 182 | 105 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 7.32e-05 | 183 | 105 | 5 | f10e72a2e2e6cdc1984f469a60244e5fd8a10095 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.51e-05 | 184 | 105 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-05 | 184 | 105 | 5 | b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.71e-05 | 185 | 105 | 5 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Club|World / Class top | 7.71e-05 | 185 | 105 | 5 | c3caf789e622ed515d143dc594158d52fdcffaef | |
| ToppCell | Club-club-14|World / Class top | 8.11e-05 | 187 | 105 | 5 | 4584de577d3736c89187e522497498e58d381c46 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.11e-05 | 187 | 105 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.11e-05 | 187 | 105 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 8.32e-05 | 188 | 105 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.32e-05 | 188 | 105 | 5 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 188 | 105 | 5 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 188 | 105 | 5 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.32e-05 | 188 | 105 | 5 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.53e-05 | 189 | 105 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.53e-05 | 189 | 105 | 5 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 8.53e-05 | 189 | 105 | 5 | 74a5e61cd820f2495dde40e766c771a31d8c4e7d | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.53e-05 | 189 | 105 | 5 | 7f78b5bb8195f99b18082cbb612e9199b7a1538c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 189 | 105 | 5 | bd91bdfe35294e60d980259b70fe9e60dca2743f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.74e-05 | 190 | 105 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 8.74e-05 | 190 | 105 | 5 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.74e-05 | 190 | 105 | 5 | 47513757e0059e8370e49672a577f25ca842e98c | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.74e-05 | 190 | 105 | 5 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.74e-05 | 190 | 105 | 5 | 773c55b9e28c2f77a5eb5f0adb0fa9862fb9611d | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.74e-05 | 190 | 105 | 5 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 8.74e-05 | 190 | 105 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.74e-05 | 190 | 105 | 5 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 8.96e-05 | 191 | 105 | 5 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 8.96e-05 | 191 | 105 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.96e-05 | 191 | 105 | 5 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.96e-05 | 191 | 105 | 5 | 6e1d00404d795ec7cf60f685e42e4ad9a16ac596 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.96e-05 | 191 | 105 | 5 | 51535232e889db52a9b24e5696b1687e93dd7302 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.96e-05 | 191 | 105 | 5 | f158e393976b685b896a41871bda1ab65a8b58f5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.96e-05 | 191 | 105 | 5 | 5d6ef70cc15ec5e983a953e547e40f9c06e355fb | |
| ToppCell | PBMC-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 9.18e-05 | 192 | 105 | 5 | 4f4774b925058191673b4ba4b4d05b8b37f61795 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.18e-05 | 192 | 105 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 193 | 105 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 193 | 105 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.41e-05 | 193 | 105 | 5 | b93f6af5999ad207fef5edc2bd900c7c6342f626 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 9.41e-05 | 193 | 105 | 5 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 9.64e-05 | 194 | 105 | 5 | 96400477d130b2403ed81c229e4e4182cc2cdc14 | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.64e-05 | 194 | 105 | 5 | a4523adbbd25c314809eed3414d66a5b323446e5 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 9.64e-05 | 194 | 105 | 5 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.64e-05 | 194 | 105 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Control / Condition, Lineage and Cell class | 9.64e-05 | 194 | 105 | 5 | a1dd264822de83a0ffaf89ca4707c6a76809359e | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.64e-05 | 194 | 105 | 5 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.64e-05 | 194 | 105 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.64e-05 | 194 | 105 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.64e-05 | 194 | 105 | 5 | 125bf2909cf89133693bc7b865ca08955cf67a2e | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.64e-05 | 194 | 105 | 5 | 4428b472c2042f88eae028b1770767512a515b75 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.87e-05 | 195 | 105 | 5 | ee8743d39996bb756f50db32748e8a902d3294b8 | |
| ToppCell | 390C-Myeloid-Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.87e-05 | 195 | 105 | 5 | 6f09bfd6394c10c90c23d130a18941bf490e1a8f | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.87e-05 | 195 | 105 | 5 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 196 | 105 | 5 | 7dff78ff7b2b333680de1c9ca78190770574d796 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-04 | 196 | 105 | 5 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | (0)_Myeloid-(000)_CD14+_Monocyte|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 1.01e-04 | 196 | 105 | 5 | e9718642ee2751c9d46a1b968547bdcb59cdfd30 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 197 | 105 | 5 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | severe_COVID-19-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.04e-04 | 197 | 105 | 5 | cdffd49db7374d223ded46d636cd4be12d464ea4 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 197 | 105 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 197 | 105 | 5 | 67bf15ee83938bd40f6ecd5abaaf90ad95096d21 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.04e-04 | 197 | 105 | 5 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | 390C-Myeloid-Monocyte-CD16+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 197 | 105 | 5 | 01f5f5c34e904cc0146e978cc05ed1cd86a41533 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 197 | 105 | 5 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 197 | 105 | 5 | 15bcfe6105c0b508811fb9bba0bc4312fea04f4c | |
| Drug | 6-Chloro-D,L-tryptophan | 4.95e-06 | 8 | 103 | 3 | CID000065259 | |
| Drug | ferrous oxalate dihydrate | 7.41e-06 | 9 | 103 | 3 | CID000516788 | |
| Disease | common bile duct disease (implicated_via_orthology) | 1.14e-05 | 2 | 100 | 2 | DOID:4137 (implicated_via_orthology) | |
| Disease | citrullinemia (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:9273 (implicated_via_orthology) | |
| Disease | intrahepatic cholestasis (implicated_via_orthology) | 6.79e-05 | 4 | 100 | 2 | DOID:1852 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 8.42e-04 | 215 | 100 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | X-17654 measurement | 1.16e-03 | 15 | 100 | 2 | EFO_0800784 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.16e-03 | 15 | 100 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.35e-03 | 64 | 100 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 1.50e-03 | 17 | 100 | 2 | C2936862 | |
| Disease | Bardet-Biedl syndrome | 1.68e-03 | 18 | 100 | 2 | cv:C0752166 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.81e-03 | 152 | 100 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | diet measurement, HOMA-B | 1.87e-03 | 19 | 100 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | Deep Vein Thrombosis | 2.29e-03 | 21 | 100 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 2.29e-03 | 21 | 100 | 2 | C0042487 | |
| Disease | reading and spelling ability | 2.49e-03 | 166 | 100 | 4 | EFO_0005301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSFTQKYPPVKFLSE | 71 | Q8NBZ7 | |
| KNPGKYKSVSAFAPI | 161 | P10768 | |
| IFSKGKPFRKPIYTN | 1061 | Q4VNC0 | |
| FSYQRSLKFRPKGKP | 211 | Q9UKH3 | |
| FFFGRTPLIKLSPKK | 261 | Q92903 | |
| LPKYTSQIVGRFIKP | 241 | Q9UNS2 | |
| KPLDVRYSFFVPKKS | 841 | Q9UNA0 | |
| RYSFFVPKKSTPKVN | 846 | Q9UNA0 | |
| PKSKFVLVKFDTQYP | 51 | P30040 | |
| GPSISYPRKVLNFKG | 846 | Q5XX13 | |
| PQFLKSKYFTPVTKN | 2981 | Q6V0I7 | |
| VPFFSAQSKPREKYK | 121 | A7E2U8 | |
| QKNKLPFDGSPKITY | 261 | B6SEH9 | |
| DFRFGTIPVKLYQPK | 91 | Q5VUY0 | |
| GRPLKSYELFKPQTK | 191 | Q6ZW61 | |
| PKVLYKSKTGKYSFP | 641 | Q8TAM1 | |
| YYLKISQPSGNPKKI | 86 | Q8IVL8 | |
| KLKPAFIKPYGTVTA | 291 | P55084 | |
| AAKLFPGSPAIYKLK | 121 | P49792 | |
| KKFVAVLAKYFPGRP | 331 | O00391 | |
| AAKLFPGSPAIYKLK | 121 | Q99666 | |
| AAKLFPGSPAIYKLK | 121 | O14715 | |
| KTYSKPIFGSVRTKP | 1341 | P23467 | |
| LRFYKNKIPFKPDGV | 121 | Q5TC84 | |
| YRFPPKFTLKAGQVV | 481 | P02545 | |
| KPFFTRNPSELKGKF | 456 | Q96QZ7 | |
| FLGIYIPPTNKFSPK | 841 | P19823 | |
| YSPSGKKFRSKPQLA | 36 | O95983 | |
| KFRLFPRPQVKLFGK | 476 | Q9UKN7 | |
| PGQPLTKNKFKVLYE | 1151 | Q10570 | |
| QKNKLPFDGSPKITY | 261 | B6SEH8 | |
| YKSFGDTKFVPNLPK | 106 | Q9NY33 | |
| PRKNFVKPNETKTYF | 1821 | P00451 | |
| QKFGSVPFTKNPEKY | 701 | Q9UPT5 | |
| SVYSPVKKKPNISGF | 136 | O15504 | |
| YFRPKSNNSPEGKKL | 246 | Q9H208 | |
| RLAKFQLKVKGYPAP | 5276 | Q5VST9 | |
| KVPYVNSPGEKYRIK | 116 | O43900 | |
| RKLKFSPIKYGYQPR | 71 | O60313 | |
| SVNYKTGPKPVRFLG | 266 | Q6PI47 | |
| KQKYLSFTPPEKDGF | 136 | Q13177 | |
| AAKLFPGSPAIYKLK | 121 | A6NKT7 | |
| IPKLKYIPLKFSFTA | 526 | Q8TD57 | |
| FPYQRSLKFRPKGKP | 101 | P61566 | |
| FSYQRSLKFRPKGKP | 101 | P61567 | |
| KGIPVYRFVLPSKAF | 286 | P16671 | |
| YKLSGFYKIKPLQSP | 91 | Q08830 | |
| FKAIKARFAKPVYPG | 556 | P51659 | |
| LGPKSFPFVKTFINK | 41 | A8TX70 | |
| FPKSYVKLISGPIRK | 961 | Q15811 | |
| KFSKPTSALYPFLGI | 16 | Q9Y375 | |
| FSYQRSLKFRPKGKP | 211 | P61565 | |
| FSYQRSLKFRPKGKP | 101 | Q9HDB8 | |
| PPKFFYTRKLLGSAL | 36 | P04839 | |
| LIPVKQYPKFNFVGK | 161 | Q07666 | |
| IPVKQYPKFNFVGKL | 66 | Q5VWX1 | |
| FGVRLKRAPPSQKYK | 1476 | Q9ULL0 | |
| PRYFIAPAKFLGKQV | 556 | P11047 | |
| SKRVPIYEKKYGQVP | 66 | Q16568 | |
| KLFPYIQKGLKSSLP | 241 | Q9H583 | |
| FIYALKAPKSFPKGD | 796 | Q9H583 | |
| KPFASISFLPYSKVG | 3971 | Q8NDH2 | |
| NTRYGGKSLVFPPKK | 336 | Q9Y238 | |
| LPPIKKNFYKESTAT | 191 | Q9NXZ2 | |
| YFSPTKGARPNIRKF | 711 | A6NMZ7 | |
| TFSPYQFKTSGPEKK | 271 | Q12923 | |
| RAAKLFPGSPAIYKL | 111 | P0DJD0 | |
| KFTSSLPKYPLGRQI | 421 | Q9UBD5 | |
| SQTGSLFKPRKAYLP | 311 | P51398 | |
| AAKLFPGSPAIYKLK | 121 | Q7Z3J3 | |
| PGATPAKRFKLNYAT | 71 | Q9NX07 | |
| FFQTIFSKKERKPAP | 1016 | B4DYI2 | |
| QKKPFTPVKYFSIDR | 341 | Q9Y285 | |
| PYFKKEKPQSTISGL | 71 | P12259 | |
| RTKKRFTPPIYQPKF | 36 | Q9BRJ2 | |
| EFFKLARRTYPKKPG | 181 | Q8N565 | |
| PRKSPKYLALFKNSV | 796 | Q7Z3K3 | |
| ALTEKFNLPPGNYKK | 11 | P05230 | |
| PGPIAQRFKKTLEKY | 296 | Q9BZQ2 | |
| KFPVTENSKGYKLLP | 331 | P43490 | |
| FRPKFLALKGPSFYV | 316 | Q9NY99 | |
| RFPKKYSYPLKSPGV | 1026 | Q07889 | |
| FTYTAKRPSDIKFKP | 171 | Q9NSD9 | |
| TVKGLLKPSFSPRNY | 16 | Q8IW75 | |
| KRKKAPLVSGPYIVY | 201 | Q9HCU9 | |
| SLGQVSFPKFYKPKF | 4856 | Q8IVF2 | |
| NKFGLYLPKFKSPSV | 651 | O75746 | |
| ENKFGLYLPLFKPSV | 651 | Q9UJS0 | |
| SDYLFKPPKIKFTNG | 56 | Q8IWF7 | |
| KTIKRPFGVKYNPYT | 391 | P17752 | |
| KIPYFRGPLQTKAKF | 321 | P57772 | |
| YFVAPRPKFSAKKSG | 1066 | Q9UMS6 | |
| PFIIKSPKQYKNLSF | 506 | Q6UVY6 | |
| PNIFFTIKYKPKQLG | 76 | Q9Y5W7 | |
| ATYNFKNEGRKKPPL | 71 | Q8N801 | |
| FSKSKKSPIGYLPFV | 746 | Q9H269 | |
| FQPPEAKKFFSTVRK | 946 | Q9C0C9 | |
| KIFSGPKRSPTKAVY | 541 | Q7Z5K2 | |
| GLIKPPKKMGTFFSY | 361 | O94885 | |
| PYPGHTKGFRVFKKS | 206 | Q9BZD6 | |
| VYFKPSLTPSGEFRK | 381 | P49790 | |
| LGPYAFKIPLSIRQK | 851 | Q8IZJ1 | |
| LGRPKSFIPSFQVYK | 616 | Q96JE7 | |
| GKRFKPSKYVPVSAA | 6 | Q9C0B5 | |
| PPSKKKRLGFFQTYD | 731 | O95789 | |
| YPTLKLFKPGQEAVK | 136 | Q8NBS9 | |
| PLIKKSYFPKILTFF | 151 | Q9C0K1 | |
| FLPKRKNPAYLKSVS | 76 | Q6PJF5 | |
| PVSFVKFSPNGKYIL | 216 | P61964 | |
| FSRKKFSPPKKIFNF | 271 | Q8TF71 | |
| FSPPKKIFNFAIFKV | 276 | Q8TF71 | |
| LSFFKPTPKRYKILL | 146 | Q16719 | |
| FKGKKDNYPQSVPRL | 881 | O00159 | |
| EKSFLVKQAPPGFYR | 716 | Q58DX5 |